ADTX (Aditxt) Forward P/E Multiple
Aditxt (ADTX) forward NTM P/E demonstrates scaling potential through cloud services and unified immune tests. However, 0.00 captures the current indicator level against a backdrop of critical funding shortages and debts that threaten the business's survival. Stability is provided only by exclusive AditxtScore patents and strict FDA control, which create significant barriers to entry for new players.
Analytical breakdowns for Aditxt
- current price and projected stock value:
- business market valuation indicators:
- book capitalization information:
- debt and liquidity details:
- company profitability and valuation multiples indicators:
ADTX - Company Profit|Projected Future Earnings Aditxt|ADTX - Business Payback Period|Projected Price to Earnings Aditxt|ADTX - Company Value to Earnings Growth Ratio|Enterprise Value to EBITDA Ratio Aditxt Inc.|ADTX - Operating profit before amortization|Net earnings per share for the last 12 months Aditxt|ADTX - Earnings per share for the last four quarters|Quarterly EPS earnings growth aditxt.com|ADTX - Earnings growth in current year|Earnings growth forecast for next year Aditxt
Summary company analytics:Aditxt, Inc.
The forward P/E determines the market value of an asset relative to expected annual earnings, allowing an investor to assess the extent of the premium paid for future income. By analyzing the forward P/E chart for Aditxt (ADTX), one can compare price action with the efficiency of Aditxt (ADTX) high-tech laboratories in the US, where automated immunity monitoring should ensure a stable cash flow and justify the current multiple.
Competitors of Aditxt (ADTX)
Projected Price to Earnings ARGX (argenx)|BNTX (BioNTech Inc.) - Future Price to Earnings Multiple|Forward P/E Multiple ABVX (abivax.com)|Market Cap to Projected Earnings ADMA Corp (ADMA)|PTGX - Future Price to Earnings|immunovant.com (IMVT) - Projected Price to Earnings|Kiniksa (KNSA) - Future Price to Earnings|Projected Price to Earnings Grifols SA|Projected Price to Earnings ADPT|Forward P/E Multiple Celldex Corp|Future Price to Earnings Aurinia Pharmaceuticals (AUPH)|biocryst.com - Price to Future Earnings Ratio|Forward P/E Multiple VERA (Vera Therapeutics)|Dianthus Therapeutics Inc (DNTH) - Projected Price to Earnings Ratio|Pharvaris Corp - Forward P/E Multiple|ABCL - Forward P/E Multiple|TRML: Forward P/E Multiple|Price to Future Earnings Ratio PGEN|PHAR (Pharming Group) - Forward P/E Multiple|Nektar Therapeutics Inc (NKTR) - Market Cap to Projected Earnings|Projected Price to Earnings UPB (Upstream Bio Corp)|Market Cap to Future Earnings Ratio ZBIO|Immunome, Inc. - Projected Price to Earnings|GOSS: Price to Future Earnings Ratio|KALV: Projected Price to Earnings|Septerna, Inc. - Market Cap to Future Earnings Ratio|PVLA: Forward P/E Multiple|Savara Pharma (SVRA) - Forward P/E Multiple|RIGL (Rigel Pharmaceuticals) - Forward P/E Multiple|Price to Future Earnings Ratio ANAB (anaptysbio.com)|Projected Price to Earnings ATXS (Astria Therapeutics, Inc.)|Market Cap to Future Earnings Ratio ENGN|RAPT Therapeutics, Inc. - Projected Price to Earnings|JBIO: Price to Future Earnings Ratio|ACRS - Future Price to Earnings|Price to Expected Earnings Ratio KYTX|TLSA: Forward P/E Multiple|Cabaletta Bio Inc. - Future Price to Earnings Multiple|VTYX (Ventyx Bio) - Forward P/E Multiple|Forward P/E Multiple Theratechnologies, Inc|Future Price to Earnings Avalo Therapeutics, Inc (AVTX)|ELDN (eledon.com) - Future Price to Earnings Multiple|Future Price to Earnings Agenus Inc. AGEN|CLYM - Projected Price to Earnings|Zura Bio Limited - Forward P/E Multiple|ATYR - Forward P/E Multiple|ADAG (adagene.com) - Projected Price to Earnings|Ikena Oncology - Future Price to Earnings Multiple|STTK (Shattuck Labs Inc) - Forward P/E Multiple|Equillium Bio (EQ) - Market Cap to Projected Earnings|Future Price to Earnings Connect Biopharma (CNTB)|Projected Price to Earnings immunic-therapeutics.com IMUX|Future Price to Earnings Atara Bio ATRA|IFRX - Projected Price to Earnings|XFOR: Projected Price to Earnings|ACET - Forward P/E Multiple|celularity.com (CELU) - Future Price to Earnings|Price to Future Earnings Ratio INMB|BRNS (Barinthus Biotherapeutics) - Forward P/E Multiple|Projected Price to Earnings Ratio kezarlifesciences.com KZR|Forward P/E Multiple SABS|Forward P/E Multiple Akari Therapeutics PLC (AKTX)|Forward P/E Multiple ENLV (Enlivex Therapeutics Ltd.)|QTTB: Price to Future Earnings Ratio|GeoVax Labs, Inc. - Forward P/E Multiple|Market Cap to Projected Earnings edesabiotech.com EDSA|IBIO (iBio) - Projected Price to Earnings|CARM: Market Cap to Future Earnings Ratio|Projected Price to Earnings XTLB|Price to Future Earnings Ratio BOLT (Bolt Bio)|Projected Price to Earnings HCWB (HCW Biologics Inc.)|Market Cap to Future Earnings Ratio APVO|Forward P/E Multiple AIM (AIM ImmunoTech)|Forward P/E Multiple GRI Bio Inc GRI|XORTX - Forward P/E Multiple|HIND (Vyome Therapeutics) - Price to Future Earnings Ratio|REVB (Revelation Biosciences) - Projected Price to Earnings|INDP: Market Cap to Future Earnings Ratio|Projected Price to Earnings SCNI|Price to Future Earnings Ratio CALI (CalciMedica Corp)|Future Price to Earnings Affimed (AFMD)|ALLK: Price to Expected Earnings Ratio|Forward P/E Multiple HOOK (HOOKIPA Pharma)|Future Price to Earnings Multiple IGMS|iTeos Therapeutics, Inc. - Forward P/E Multiple|OCEA - Forward P/E Multiple|TC BioPharm (Holdings) PLC (TCBP) - Future Price to Earnings|Third Harmonic Bio Inc - Future Price to Earnings Multiple
